Hair for the Long Haul: Alopecia Areata Cases and Considerations

    December 2025 in “ Dermatology The American Medical Journal ”
    Helen Boreham
    Studysummary In this conference session, experts reviewed clinical evidence and strategies for using JAK inhibitors in managing alopecia areata, emphasizing optimal treatment practices and individual patient considerations to enhance safety and effectiveness in real-world settings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on emjreviews.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO-LT Phase 3, Open-Label Study SKIN The Journal of Cutaneous Medicine · 2025
    2. Patient-Reported Outcomes for Scalp, Eyebrow, and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from Two Phase 3 Clinical Trials Journal of the American Academy of Dermatology · 2024